Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 16/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MET | P08581 | 1/20 | 0.39 |
| ▸ | AXL | P30530 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29349968 | 1.00 | CHRM3 (0.51) | CHRM3CHRM2CHRM1ALOX15LMNA | |
| SCHEMBL29445383 | 1.00 | CHRM3 (0.51) | CHRM3CHRM2CHRM1ALOX15LMNA | |
| SCHEMBL31265248 | 0.93 | CHRM3 (0.51) | CHRM3CHRM2CHRM1 | |
| SCHEMBL1136276 | 0.93 | CHRM3 (0.51) | CHRM3CHRM2CHRM1 | |
| SCHEMBL29688317 | 0.93 | CHRM3 (0.51) | CHRM3CHRM2CHRM1ALOX15 | |
| SCHEMBL303047 | 0.93 | CHRM3 (0.51) | CHRM3CHRM2CHRM1ALOX15 | |
| SCHEMBL19274807 | 0.92 | CHRM3 (0.45) | CHRM3CHRM2CHRM1LMNATHRB | |
| SCHEMBL1092101 | 0.92 | CHRM3 (0.51) | CHRM3CHRM2CHRM1THRB | |
| SCHEMBL29437140 | 0.92 | CHRM3 (0.42) | CHRM3CHRM2CHRM1ALOX15LMNA | |
| SCHEMBL304334 | 0.92 | CHRM3 (0.42) | CHRM3CHRM2CHRM1ALOX15LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1957 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4410100-A2 | PLANT HEALTH COMPOSITION | BASF SE (DE) | 2024-08-07 | — | — | EP | claimed |
| EP-3954214-A1 | MULTIPURPOSE BIOLOGICAL COMPOSITIONS | Agrivalle Brasil Industria e Comércio de Produtos Agrícolas Ltda (BR) | 2022-02-16 | — | — | EP | claimed |
| EP-3381289-B1 | COMBINATIONS COMPRISING A FUNGICIDAL STRAIN AND AN ACTIVE COMPOUND | BAYER CROPSCIENCE LP (US) | 2021-05-05 | — | — | EP | claimed |
| US-10834921-B2 | Foam formulations and apparatus for delivery | FMC CORPORATION (US) | 2020-11-17 | — | — | US | claimed |
| EP-2292098-B1 | Combinations comprising a fungicidal strain and at least one additional fungicide | BAYER CROPSCIENCE LP (US) | 2019-11-06 | — | — | EP | claimed |
| EP-3510869-A1 | COMBINATIONS COMPRISING A FUNGICIDAL STRAIN AND AN ACTIVE COMPOUND | Bayer Cropscience LP (US) | 2019-07-17 | — | — | EP | claimed |
| EP-2489262-B1 | PESTICIDAL MIXTURES COMPRISING AN ANTHRANILAMIDE INSECTICIDE AND A FUNGICIDE | BASF SE (DE) | 2018-11-14 | — | — | EP | claimed |
| EP-3381289-A1 | COMBINATIONS COMPRISING A FUNGICIDAL STRAIN AND AN ACTIVE COMPOUND | Bayer Cropscience LP (US) | 2018-10-03 | — | — | EP | claimed |
| US-20180263243-A1 | NOVEL PLANT PROTECTING COMPOSITIONS AND USES THEREOF | FLECHSIG PATENT COMPANY LLC (CH) | 2018-09-20 | — | — | US | claimed |
| US-9844220-B2 | Synergistic fungicidal active substance combinations | FMC CORPORATION (US) | 2017-12-19 | — | — | US | claimed |
| WO-2007031507-A1 | FUNGICIDE COMPOSITION COMPRISING AN ARYLAMIDINE DERIVATIVE AND TWO KNOWN FUNGICIDE COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2007-03-22 | — | — | WO | claimed |
| WO-2007031141-A1 | SYNERGISTIC FUNGICIDAL ACTIVE SUBSTANCE COMBINATIONS CONTAINING A CARBOXAMIDE, AN AZOLE, A SECOND AZOLE OR A STROBILURINE | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2007-03-22 | — | — | WO | claimed |
| US-20070060579-A1 | Synergistic fungicidal active substance combinations | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | claimed |
| EP-1751109-A1 | FUNGICIDAL COMPOSITION COMPRISING A PYRIDYLETHYLBENZAMIDE DERIVATIVE AND A COMPOUND CAPABLE OF INHIBITING THE TRANSPORT OF ELECTRONS OF THE RESPIRATORY CHAIN IN PHYTOPATHOGENIC FUNGAL ORGANISMS | Bayer CropScience S.A. (FR) | 2007-02-14 | — | — | EP | claimed |
| EP-1742533-A1 | USE OF ALKYKL CARBOXYLIC ACID AMIDES AS PENETRATION PROMOTERS | Bayer CropScience Aktiengesellschaft (DE) | 2007-01-17 | — | — | EP | claimed |
| WO-2006136551-A1 | FUNGICIDE COMPOSITION COMPRISING A PHOSPHOROUS ACID DERIVATIVE, A MANDELAMIDE TYPE COMPOUND AND A FURTHER FUNGICIDE COMPOUND | BAYER CROPSCIENCE SA (FR) | 2006-12-28 | — | — | WO | claimed |
| WO-2006131230-A2 | ACTIVE SUBSTANCE COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006032356-A1 | SYNERGISTIC FUNGICIDAL ACTIVE SUBSTANCE COMBINATIONS WHICH CONTAIN SPIROXAMINE, A TRIAZOLE AND A CARBOXAMIDE | BAYER CROPSCIENCE AG (DE) | 2006-03-30 | — | — | WO | claimed |
| WO-2005104844-A1 | USE OF ALKYKL CARBOXYLIC ACID AMIDES AS PENETRATION PROMOTERS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2005-11-10 | — | — | WO | claimed |
| WO-2005077901-A1 | FUNGICIDAL COMPOSITION COMPRISING A PYRIDYLETHYLBENZAMIDE DERIVATIVE AND A COMPOUND CAPABLE OF INHIBITING THE TRANSPORT OF ELECTRONS OF THE RESPIRATORY CHAIN IN PHYTOPATHOGENIC FUNGAL ORGANISMS | BAYER CROPSCIENCE SA (FR) | 2005-08-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060579-A1 | Synergistic fungicidal active substance combinations | CYP51A1, CYP1A2, CYP4X1 | CHRM3 94/4885CHRM2 111/4885CHRM1 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.